Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal pigment epithelial cell (RPE cell)
- Target
- RPE cell
- Molecular classification
- Other (Specialized epithelial cell; not a protein, enzyme, receptor, transporter, etc.)
01
Overview
The **retinal pigment epithelial cell** (RPE cell) is a highly specialized, pigmented epithelial cell forming a monolayer at the outermost layer of the retina, situated between the neural retina and the choroid. These cells perform essential roles in ocular physiology: they phagocytose photoreceptor outer segment debris, recycle vitamin A derivatives for the visual cycle, mediate selective transport of nutrients and ions, maintain the blood-retinal barrier, absorb stray light via melanin to protect the retina, and secrete growth factors and immunomodulatory substances. Dysfunction or loss of RPE cells is central in the pathology of multiple blinding retinal diseases.
- Other names
- Retinal pigment epithelium cellRPE cellRetinal pigmented epithelial cell
02
Mechanism of action
Not applicable to the cell itself, but some therapies target gene/protein deficiencies within RPE cells (e.g., gene therapy for RPE65 deficiency).
03
Biological functions
Visual cycle maintenance (re-isomerization of retinal and recycling of vitamin A)Phagocytosis (engulfment and digestion of shed photoreceptor outer segments)Formation of the blood-retinal barrierAbsorption of stray light via melanin pigmentProtection against oxidative stressTransport of nutrients, water, ions, and metabolic wasteSecretion of growth factors and immune modulation
04
Disease associations
Degenerative retinal diseases (e.g., age-related macular degeneration, retinitis pigmentosa)Inherited retinal dystrophies (e.g., mutations in RPE65 cause Leber congenital amaurosis)Inflammation-related retinal disordersContribution to blindness when dysfunctional
05
Safety considerations
Therapy targeting or involving RPE cells (e.g., gene therapy, transplantation) can raise concerns such as immune rejection, risk of tumorigenesis (with stem cell-derived RPE), or off-target effects.
06
Interacting drugs
None directly, as RPE cells are not a single druggable target.
1 more in the full profile.
07
Biomarkers
RPE65 protein for inherited retinal dystrophyPigment content, autofluorescence, and functional measures (e.g., electrooculogram for RPE function)
Beyond the preview
Go deeper on Retinal pigment epithelial cell (RPE cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Retinal pigment epithelial cell (RPE cell).